Superior immunogenic effects of IL-6 gene-simultaneously-transfected dendritic cell/TGF-β1-expressed cell fusion vaccine
碩士 === 國立交通大學 === 生物科技系所 === 97 === Dendritic cell (DC)-based antitumor vaccine is a promising immunotherapy for cancer in recent years. However, the clinical results in the clinical trails showed that the treatments of DC vaccines benefit only a subset of patients to result in tumor regression. One...
Main Authors: | Wen, Li-Yuan, 溫立筠 |
---|---|
Other Authors: | Liao, Kuang-Wen |
Format: | Others |
Language: | en_US |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/43486155218926043887 |
Similar Items
-
MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy.
by: Susanna J Dunachie, et al.
Published: (2010-09-01) -
Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines
by: Lien eVandenberk, et al.
Published: (2016-01-01) -
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
by: Jan Dörrie, et al.
Published: (2020-01-01) -
Study on the Inhibition of Tumor Growth by MIP-1α-transfected Tumor Cell Vaccine and Dendritic Cell Vaccine
by: Yi-Ming Kao, et al.
Published: (2004) -
Established the lentiviral IL-10 or TGF-β1 vectors for murine dendritic cells and mesenchymal stroma cells transduction
by: Shen Kai-Lun, et al.
Published: (2009)